🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rei Goto

Keio University

ORCID: 0000-0002-7484-4957

Also affiliated with Keio University Hospital

Economics, Econometrics and FinanceEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma in Japan”.

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma in Japan

Value in Health Regional Issues(2024)10.1016/j.vhri.2023.11.003

N/A

0DataRank · unranked

2 citations

Kensuke Moriwaki, Kosuke Morimoto, Xiuting Mo, Takashi Yoshioka, Rei Goto +2 more

Primary Care Physician Characteristics and Low-Value Care Provision in Japan

JAMA Health Forum(2025)10.1001/jamahealthforum.2025.1430

N/A

0DataRank · unranked

6 citations

John N. Mafi, Kazuhiro Abe, Alexandra M. Klomhaus, Rei Goto, Kei Kitajima +3 more

Low-cost, high-volume healthcare services contribute the most to low-value care spending in Japan

Health Affairs Scholar(2025)10.1093/haschl/qxaf225

N/A

0DataRank · unranked

0 citations

John N. Mafi, Tsuguya Fukui, Yuya Kimura, Daiki Kobayashi, Sara Odawara +4 more